株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アレルギー血液検査:パイプライン製品の分析

Allergy Blood Tests - Pipeline Review, 2015

発行 GlobalData 商品コード 333506
出版日 ページ情報 英文 32 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
アレルギー血液検査:パイプライン製品の分析 Allergy Blood Tests - Pipeline Review, 2015
出版日: 2015年05月25日 ページ情報: 英文 32 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中のアレルギー血液検査関連のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • アレルギー血液検査の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)

第4章 アレルギー血液検査:開発中のパイプライン製品 (企業別)

  • アレルギー血液検査の開発企業:開発段階別のパイプライン製品
  • アレルギー血液検査:開発段階別のパイプライン製品

第5章 アレルギー血液検査の開発企業・製品の概要

  • Abionic SA:企業概要
    • パイプライン製品および進行中の治験の概要
  • Amerimmune:企業概要
  • Atomo Diagnostics Pty Limited:企業概要
  • AXO Science S.A.S.:企業概要
  • Bioftalmik Applied Research:企業概要
  • Children's Hospital Boston:企業概要
  • Cincinnati Children's Hospital Medical Center:企業概要
  • Cytognos, S.L.:企業概要
  • Hycor Biomedical Inc.:企業概要
  • Sistemas Genomicos, S.L.:企業概要
  • St. Jude Children's Research Hospital, Inc.:企業概要
  • The Binding Site Group Ltd.:企業概要
  • The University of Queensland:企業概要

第6章 アレルギー血液検査:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0019EPD

GlobalData's Medical Devices sector report, "Allergy Blood Tests - Pipeline Review, 2015" provides an overview of Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Allergy Blood Tests products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Allergy Blood Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Allergy Blood Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Allergy Blood Tests Overview

3. Products under Development

  • 3.1. Allergy Blood Tests - Pipeline Products by Stage of Development
  • 3.2. Allergy Blood Tests - Pipeline Products by Territory
  • 3.3. Allergy Blood Tests - Pipeline Products by Regulatory Path
  • 3.4. Allergy Blood Tests - Pipeline Products by Estimated Approval Date

4. Allergy Blood Tests - Pipeline Products under Development by Companies

  • 4.1. Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Allergy Blood Tests - Pipeline Products by Stage of Development

5. Allergy Blood Tests Companies and Product Overview

  • 5.1. Abionic SA Company Overview
    • 5.1.1. Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Amerimmune Company Overview
    • 5.2.1. Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Atomo Diagnostics Pty Limited Company Overview
    • 5.3.1. Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. AXO Science S.A.S. Company Overview
    • 5.4.1. AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Bioftalmik Applied Research Company Overview
    • 5.5.1. Bioftalmik Applied Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Children's Hospital Boston Company Overview
    • 5.6.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Cincinnati Children's Hospital Medical Center Company Overview
    • 5.7.1. Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cytognos, S.L. Company Overview
    • 5.8.1. Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Hycor Biomedical Inc. Company Overview
    • 5.9.1. Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Sistemas Genomicos, S.L. Company Overview
    • 5.10.1. Sistemas Genomicos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. St. Jude Children's Research Hospital, Inc. Company Overview
    • 5.11.1. St. Jude Children's Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. The Binding Site Group Ltd. Company Overview
    • 5.12.1. The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. The University of Queensland Company Overview
    • 5.13.1. The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview

6. Allergy Blood Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 2: Allergy Blood Tests - Pipeline Products by Territory
  • Table 3: Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Table 4: Allergy Blood Tests - Pipeline Products by Estimated Approval Date
  • Table 5: Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • Table 6: Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 7: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: abioKIT - Product Status
  • Table 9: abioKIT - Product Description
  • Table 10: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Basophile Panel - Product Status
  • Table 12: Basophile Panel - Product Description
  • Table 13: CD69 and IgE Receptor Expression Assay - Product Status
  • Table 14: CD69 and IgE Receptor Expression Assay - Product Description
  • Table 15: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: AtomoRapid - Allergy - Product Status
  • Table 17: AtomoRapid - Allergy - Product Description
  • Table 18: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Companion Diagnostic Test - Allergy - Product Status
  • Table 20: Companion Diagnostic Test - Allergy - Product Description
  • Table 21: Diagnostic Test - Allergy - Product Status
  • Table 22: Diagnostic Test - Allergy - Product Description
  • Table 23: Bioftalmik Applied Research Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Diagnostic Test - Pediatric Occular Allergy - Product Status
  • Table 25: Diagnostic Test - Pediatric Occular Allergy - Product Description
  • Table 26: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Biomarker Assay - Allergy - Product Status
  • Table 28: Biomarker Assay - Allergy - Product Description
  • Table 29: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Genetic Marker Diagnostic Test - Food Allergy - Product Status
  • Table 31: Genetic Marker Diagnostic Test - Food Allergy - Product Description
  • Table 32: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status
  • Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description
  • Table 35: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status
  • Table 37: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description
  • Table 38: HYTEC 288 PLUS - Tryptase Test - Product Status
  • Table 39: HYTEC 288 PLUS - Tryptase Test - Product Description
  • Table 40: Sistemas Genomicos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Inmutest - Product Status
  • Table 42: Inmutest - Product Description
  • Table 43: St. Jude Children's Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Diagnostic Assay - Allergic Disease - Product Status
  • Table 45: Diagnostic Assay - Allergic Disease - Product Description
  • Table 46: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: SPA PLUS - IgE Assay - Product Status
  • Table 48: SPA PLUS - IgE Assay - Product Description
  • Table 49: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Diagnostic Assay - Allergy - Product Status
  • Table 51: Diagnostic Assay - Allergy - Product Description
  • Table 52: Glossary

List of Figures

  • Figure 1: Allergy Blood Tests - Pipeline Products by Stage of Development
  • Figure 2: Allergy Blood Tests - Pipeline Products by Territory
  • Figure 3: Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Figure 4: Allergy Blood Tests - Pipeline Products by Estimated Approval Date
Back to Top